Euroseeds, a group representing more than 36 national member associations and 67 direct company members in the European Union advocates for science-based decision-making with the aim of contributing to a fair and proportionate regulation of the European seed sector, freedom of choice for customers, and effective protection of intellectual property rights.

Euroseeds is responding to the European Greens/EFA group and their recent report with the following points:

• - NGTs applications are versatile and can be used in the development of a wide range of different products. One type of product is GMOs, however, other types of new genomics techniques (NGT)-derived plants are similar to those that could occur in nature or developed through conventional breeding methods.
• - There is a broad scientific consensus that the applications of NGTs resulting in conventional-like plants are also as safe as conventional breeding (EFSA, Scientific opinion on plants developed using SDN-1&2 and ODM).
• - It is not possible to distinguish NGT-derived plants from products that were developed by using conventional breeding processes that do not lead to regulated GMO products (as confirmed by the joint research center of the EU, JRC, as well as the European network of GMO laboratories).

Euroseeds reiterates its commitment to more sustainable agriculture and plant breeding with a proven track record of contributing to this goal. “The EC's study shows that there is a broad scientific consensus about NGTs and that's why we will continue advocating for our members' efforts on this very important topic”, says Garlich von Essen, Secretary General of Euroseeds.

For more details, read the article on the Euroseeds website.